KIR3DL2 and cancer: For our fourth cancer, SKCM, KIR3DL2 showed significant evidence (nominal p < 0.05) for differential coexpression with 3 of the 4 soft thresholds analyzed, and was non-significant at the threshold of 0.05 (nominal p = 0.069) for the fourth soft threshold.